Importantly, these findings reveal a dominant role for HSPA6 and HSPA5 in the CTCL adaptive response to ER stress-inducing drugs, leading us to hypothesize that these Hsp70 family members are attractive drug targets in CTCL. The gene discussed is HSPA5; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.